| Literature DB >> 32411620 |
Shihui Zhou1,2,3,4,5,6, Xueting Tu1,2,3,4,5,6, Huanying Pang1,2,3,4,5,6, Rowena Hoare7, Sean J Monaghan7, Jiajun Luo2,3,4, Jichan Jian2,3,4,5,6.
Abstract
Vibrio alginolyticus is a major cause of Vibriosis in farmed marine aquatic animals and has caused large economic losses to the Asian aquaculture industry in recent years. Therefore, it is necessary to control V. alginolyticus effectively. The virulence mechanism of V. alginolyticus, the Type III secretion system (T3SS), is closely related to its pathogenicity. In this study, the T3SS gene tyeA was cloned from V. alginolyticus wild-type strain HY9901 and the results showed that the deduced amino acid sequence of V. alginolyticus tyeA shared 75-83% homology with other Vibrio spp. The mutant strain HY9901ΔtyeA was constructed by Overlap-PCR and homologous recombination techniques. The HY9901ΔtyeA mutant exhibited an attenuated swarming phenotype and an ~40-fold reduction in virulence to zebrafish. However, the HY9901ΔtyeA mutant showed no difference in growth, biofilm formation and ECPase activity. Antibiotic susceptibility test was observed that wild and mutant strains were extremely susceptible to Amikacin, Minocycline, Gentamicin, Cefperazone; and resistant to oxacillin, clindamycin, ceftazidime. In contrast wild strains are sensitive to tetracycline, chloramphenicol, kanamycin, doxycycline, while mutant strains are resistant to them. qRT-PCR was employed to analyze the transcription levels of T3SS-related genes, the results showed that compared with HY9901 wild type, ΔtyeA had increased expression of vscL, vscK, vscO, vopS, vopN, vscN, and hop. Following vaccination with the mutant strain, zebrafish had significantly higher survival than controls following infection with the wild-type HY9901 (71.2% relative percent survival; RPS). Analysis of immune gene expression by qPCR showed that vaccination with HY9901ΔtyeA increased the expression of IgM, IL-1β, IL-6, and TNF-α in zebrafish. This study provides evidence of protective efficacy of a live attenuated vaccine targeting the T3SS of V. alginolyticus which may be facilitated by up-regulated pro-inflammatory and immunoglobulin-related genes.Entities:
Keywords: Vibrio alginolyticus; live attenuated vaccine; regulator; tyeA; type III secretory system
Mesh:
Substances:
Year: 2020 PMID: 32411620 PMCID: PMC7198820 DOI: 10.3389/fcimb.2020.00183
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 5.293
Bacterial strains, plasmids, and experimental fish used in this study.
| Wild type, isolated from diseased | (Cai et al., | |
| supE44 ΔlacU169 (ϕ80 lacZDM15) hsdR17 recA1 gyrA96 thi-1 relA1 | TakaRa | |
| MC1061 (λpir) | lacY1 galK2 ara-14 xyl-5 supE44 λpir | (Rubirés et al., |
| pRE112 | pGP704 suicide plasmid, pir dependent, oriT, oriV, sacB, C mr | (Edwards et al., |
| S17-1 (λpir) | T prSmrrecA thi pro hsdR-M+RP4:2-Tc: Mu: K m T n7 λpir | (Simon et al., |
| S17-1-pRE-ΔtyeA | S17-1 containing plasmid of pRE-Δ | This study |
| pMD18-T | Cloning vector, Ampr | TakaRa |
| Zebrafish | experimental fish, purchased from Zhanjiang Aquatic Market | Zhanjiang Aquatic Market |
Sequences of primers used in this study.
| tyeA-for | GGAATCTAGACCTTGAGTCGATATCTCGACCATCGCGCAA | |
| tyeA-int-rev | ATCTTCCCACGCTTCCTCTTCAACTTGATAAGCCATAATTCGTCC | |
| tyeA-int-for | GGACGAATTATGGCTTATCAAGTTGAAGAGGAAGCGTGGGAAGAT | |
| tyeA-rev | ACAGCTAGCGACGATATGTCAGGCCGGAGGTCATAGAGCT | |
| tyeA-up | CACATGAACTCGTTTCGGACTATT | |
| tyeA-down | TTTCTGGACGCAACAACTCTGA | |
| tyeAP1-F | ATGGCTTATCAAGTTTCTA | |
| tyeAP1-R | TCAATCCAACTCATCTTCC | |
| IL-6-F | GGTCAGACTGAATCGGAGCG | |
| IL-6-R | CAGCCATGTGGCGAACG | |
| IL-6R-F | GCATGTGCTTAAAGTATCCTGGTC | |
| IL-6R-R | TGCAAATTGTGGTCGGTATCTC | |
| IL-1β-F | TGGACTTCGCAGCACAAAATG | |
| IL-1β-R | GTTCACTTCACGCTCTTGGATG | |
| IL-8-F | GTCGCTGCATTGAAACAGAA | |
| IL-8-R | CTTAACCCATGGAGCAGAGG | |
| IgM-F | GTTCCTGACCAGTGCAGAGA | |
| IgM-R | CCTGATCACCTCCAGCATAA | |
| TNF-α-F | TAGAACAACCCAGCAAAC | |
| TNF-α-R | ACCAGCGGTAAAGGCAAC | |
| rag-1-F | GAAGTATACCAGAAGCCTAAT | |
| rag-1-R | TTCCATTCATCCTCATCACA | |
| TLR5-F | GAAACATTCACCTGGCACA | |
| TLR5-R | CTACAACCAGCACCACCAGAATG | |
| c/ebpβ-F | GCCGTACCAGACTGCTCCGA | |
| c/ebpβ-R | AGCCGCTTCTTGCCTTTCCC | |
| β-actin-F | ATGGATGAGGAAATCGCTGCC | |
| β-actin-R | CTCCCTGATGTCTGGGTCGTC | |
| vscL-F | TACCACGGTGAGTGTAGTTC | |
| vscL-R | CGTAACCGACTTCAGGGA | |
| hop-F | CTTCGCTTTCGGTTTGCT | |
| hop-R | AATACCATCCCACCCTGT | |
| vscO-F | GAGCTGGAAACATTAAGACA | |
| vscO-R | TTGCTGCAACTGAACGAA | |
| vscK-F | GGCGTTATCTCCCGTTCC | |
| vscK-R | CTCCGCCCACCATCAATA | |
| vopN-F | TGAACTCGTTTCGGACTA | |
| vopN-R | ACTTTCTGGACTCGCACT | |
| vscN-F | TAGGCGAAGAAGGAATGG | |
| vscN-R | GCGATAGAAGTGGCAACAA | |
| vopS-F | AGTTTTGGAAGTGTTAGCG | |
| vopS-R | ACATTGCCTCTGTCATCG | |
| 16S-F | TTGCGAGAGTGAGCGAATCC | |
| 16S-R | ATGGTGTGACGGGCGGTGTG |
Experiment of LD50.
| 108 | 10 × 3 | 90 | 10 x 3 | 66.7 | – | – |
| 107 | 10 × 3 | 80 | 10 x 3 | 40 | – | – |
| 106 | 10 × 3 | 60 | 10 x 3 | 10 | – | – |
| 105 | 10 × 3 | 20 | 10 x 3 | 0 | – | – |
| 104 | 10 × 3 | 20 | 10 x 3 | 0 | – | – |
| 0(PBS) | – | – | – | – | 10 × 3 | 0 |
Each experiment involved 110 zebrafish with 10 fish per group in three replicate tanks and the experiment was repeated three times (total fish = 330).
Figure 1Cloning of tyeA gene. M: DL2000 marker. Lane 1-5:The 285bp fragment was amplified from genomic DNA of the wild-type strain HY9901 using primer pairs of tyeAP1-for/tyeAP1-rev (Lane 1, 2, 3, 4, 5:Tm = 56°C, 57°C, 58°C, 59°C, 60°C).
Figure 2Homology comparison of Vibrio parahaemolyticus HY9901 T3SS Regulator Protein TyeA. Vibrio alginolyticus T3SS regulatory protein TyeA Accession No.ACY41068.1; Vibrio parahaemolyticus T3SS regulatory protein TyeA Accession No.ANB96904.1; Vibrio harveyi T3SS regulatory protein TyeA Accession No.SQA36766.1; Vibrio campbellii T3SS regulatory protein TyeA Accession NO.AQM67418.1; Vibrio tubiashii T3SS regulatory protein TyeA Accession No.WP_004745559.1; Vibrio bivalvicida T3SS regulatory protein TyeA Accession No.OAJ92073.1.
Figure 3Construction and confirmation of the knockout mutant strain HY9901ΔtyeA. (A) M: DL2000 marker; Lane 1. The 549 bp upstream fragment amplified from genomic DNAs of the strain HY9901 using primer pairs of tyeA-for/tyeA-int-rev; Lane 2. The 543 bp downstream fragment amplified from genomic DNAs of the strain HY9901 using primer pairs of tyeA-int-for / tyeA-rev. (B) M: DL2000 marker; Lane 1. The 1,092 bp fragment amplified from genomic DNAs of HY9901ΔtyeA using primer pairs of tyeA-for/tyeA-rev. (C) M: DL2000 marker; Lane 1–7. The 1,104 bp fragment amplified from genomic DNAs of the HY9901ΔtyeA using primer pairs of tyeA-for/tyeA-rev; Lane 8. The 1,329 bp fragment amplified from genomic DNAs of the wild-type strain HY9901 using primer pairs of tyeA-for/tyeA-rev. (D) M: DL2000 marker; Lane 1–10. The 1,252 bp fragment amplified from genomic DNAs of HY9901ΔtyeA; Lane11. The 1,489 bp fragment amplified from genomic DNAs of the strain HY9901 using primer pairs of tyeA-up / tyeA-down.
Figure 4Genetic stability detection of HY9901ΔtyeA deletion mutant. M: DL2000 marker, Lane 1. A fragment of 1,489 bp is obtained for HY9901 using primer pairs of tyeA-up/tyeA-down. Lane 2. A fragment of 1,252 bp is obtained for HY9901ΔtyeA using primer pairs of tyeA-up/tyeA-down.
Figure 5Growth rates of HY9901ΔtyeA and HY9901. Aliquots of cell culture were taken at various time points and measured for cell density at OD600.
Comparison of biological characteristics between HY9901 and HY9901ΔtyeA.
| Activity of ECPase(A422) | 1.03 ± 0.2 | 0.97 ± 0.2 |
| Biofilm thickness(μm) | 60 ± 10 | 90 ± 20 |
| Swarming (mm) | 34.9 ± 0.2 | 20.6 ± 0.4 |
| LD50(CFU mL−1) | 5.8 × 105 | 2.6 × 107 |
Values are mean ± standard deviation for three trials. Significant differences between HY9901 and HY9901ΔtyeA indicated by asterisk.
p < 0.01.
Bacteria were incubated in TSB for 18 h at 28°C.
Bacteria were incubated in a glass bottom culture dish (NEST) for 24 h at 28°C.
Swarming diameters were measured after 24 h incubation on TSA containing 0.3% agar plates.
LD.
Figure 6Measurement of biofilm by crystal violet ammonium oxalate. *indicates significant difference compared with the control group (p < 0.05). **indicates extremely significant difference compared with the control group (p < 0.01).
Figure 7Measurement of biofilm by LSCM. (A) HY9901 2.5d diagram. (B) HY9901ΔtyeA 2.5d diagram. (C) HY9901 2d diagram. (D) HY9901ΔtyeA 2d diagram; HY9901 Biofilm thickness:60 ± 10 μm, HY9901ΔtyeA Biofilm thickness:90 ± 20 μm.
Drug sensitivity test results of the HY9901 and HY9901ΔtyeA.
| Cefperazone | 75 | 0 | R | 0 | R |
| Oxacillin | 1 | 0 | R | 0 | R |
| Clindamycin | 2 | 0 | R | 0 | R |
| Ceftazidime | 30 | 0 | R | 0 | R |
| Penicillin | 10U | 0 | R | 0 | R |
| Ampicillin | 100 | 0 | R | 0 | R |
| Caebenicillin | 100 | 0 | R | 0 | R |
| Cefazolin | 30 | 8.0 ± 0.2 | R | 0 | R |
| Ceftriaxone | 30 | 9.3 ± 0.3 | R | 0 | R |
| Cephradine | 30 | 0 | R | 0 | R |
| Piperacillin | 100 | 0 | R | 0 | R |
| Cefuroxime | 30 | 0 | R | 0 | R |
| SMZ/TMP | 23.75/1.25 | 0 | R | 0 | R |
| Aboren | 30 | 0 | R | 0 | R |
| Vancomycin | 30 | 0 | R | 0 | R |
| Cephalexin | 30 | 0 | R | 0 | R |
| polymxinB | 200IU | 0 | R | 0 | R |
| Norfloxacin | 10 | 0 | R | 0 | R |
| Ofloxacin | 5 | 0 | R | 0 | R |
| Ciprofloxacin | 5 | 0 | R | 0 | R |
| Amikacin | 30 | 13.3 ± 0.3 | I | 10.0 ± 0.1 | I |
| Minocyline | 30 | 18.5 ± 0.2 | S | 14.3 ± 0.3 | I |
| Tetracyline | 30 | 13.5 ± 0.2 | I | 12.5 ± 0.2 | R |
| Gentamicin | 10 | 14.5 ± 0.1 | I | 12.5 ± 0.2 | I |
| Furazolidone | 300 | 10.5 ± 0.4 | R | 8.0 ± 0.1 | R |
| Chloramphenicol | 30 | 17.2 ± 0.3 | S | 0 | R |
| kanamycin | 30 | 14.1 ± 0.2 | I | 12.1 ± 0.2 | R |
| Erythromycin | 15 | 10.1 ± 0.2 | R | 0 | R |
| Doxycycline | 30 | 16.5 ± 0.3 | S | 10.6 ± 0.1 | R |
| Cefperazone | 30 | 14.2 ± 0.3 | I | 13.3 ± 0.3 | I |
S(susceptible) I(intermediate) R(resistance).
Figure 8Expression of HY9901 and HY9901ΔtyeA T3SS-related genes induced by DMEM. ΔtyeA had significantly increased expression of vscL, vscK, vscO, vopS (p < 0.05), vopN, vscN, and hop (p < 0.01). * indicates significant difference compared with the control group (p < 0.05). ** indicates extremely significant difference compared with the control group (p < 0.01).
Figure 9Survival in groups vaccinated with HY9901ΔtyeA and PBS following challenge with Vibrio alginolyticus HY9901.
Figure 10Comparative analysis of the expression of immune-related genes in liver and spleen of zebrafish given the live attenuated vaccine and unvaccinated zebrafish. The head kidney and spleen of grouper were sampled at 1 day before challenge, and the mRNA level of each immune-related gene was normalized to that of β-actin. Bars represent the mean relative expression of three biological replicates and error bars represent standard deviation.